In cardiac myocytes, decreased miR-133 levels during pathological hypertrophy led to increased Ctgf and collagen synthesis and resultant heart failure [56], and was also associated with increased levels of RhoA, which inhibits axon growth and regeneration [71], and is involved in cardiac hypertrophy [52, 53]. Here, CCN2 is linked to cardiac hypertrophy.